Liu L, Zhao Y, Yang W, Han L, Mo X, Sheng J
Int J Mol Sci. 2025; 26(4).
PMID: 40004140
PMC: 11855768.
DOI: 10.3390/ijms26041676.
Sun N, Ogulur I, Mitamura Y, Yazici D, Pat Y, Bu X
Allergy. 2024; 79(12):3192-3237.
PMID: 39370939
PMC: 11657050.
DOI: 10.1111/all.16318.
Ashique S, Mohanto S, Ahmed M, Mishra N, Garg A, Chellappan D
Heliyon. 2024; 10(13):e34092.
PMID: 39071627
PMC: 11279763.
DOI: 10.1016/j.heliyon.2024.e34092.
Ozdemir C, Kucuksezer U, Ogulur I, Pat Y, Yazici D, Ardicli S
Curr Allergy Asthma Rep. 2024; 24(7):331-345.
PMID: 38884832
PMC: 11233349.
DOI: 10.1007/s11882-024-01149-7.
Khan N, Kurnik-Lucka M, Latacz G, Gil K
Int J Mol Sci. 2024; 25(10).
PMID: 38791603
PMC: 11122119.
DOI: 10.3390/ijms25105566.
Molecular Mechanisms of , LGG Probiotic Function.
Leser T, Baker A
Microorganisms. 2024; 12(4).
PMID: 38674738
PMC: 11051730.
DOI: 10.3390/microorganisms12040794.
Involvement and repair of epithelial barrier dysfunction in allergic diseases.
Lu H, Zhou Y, Yang L, Zhou Q, Wang X, Qiu S
Front Immunol. 2024; 15:1348272.
PMID: 38361946
PMC: 10867171.
DOI: 10.3389/fimmu.2024.1348272.
Recent advances in the epithelial barrier theory.
Pat Y, Yazici D, DAvino P, Li M, Ardicli S, Ardicli O
Int Immunol. 2024; 36(5):211-222.
PMID: 38227765
PMC: 10989673.
DOI: 10.1093/intimm/dxae002.
Ozone Environmental Pollution: Relationship between the Intestine and Neurodegenerative Diseases.
Rivas-Arancibia S, Miranda-Martinez A, Rodriguez-Martinez E, Hernandez-Orozco E, Valdes-Fuentes M, De la Rosa-Sierra R
Antioxidants (Basel). 2023; 12(7).
PMID: 37507863
PMC: 10376557.
DOI: 10.3390/antiox12071323.
The epithelial barrier theory: Development and exacerbation of allergic and other chronic inflammatory diseases.
Kucuksezer U, Ozdemir C, Yazici D, Pat Y, Mitamura Y, Li M
Asia Pac Allergy. 2023; 13(1):28-39.
PMID: 37389096
PMC: 10166244.
DOI: 10.5415/apallergy.0000000000000005.
Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.
Proano A, Viteri J, Orozco E, Calle M, Costa S, Reyes D
Neurol Int. 2023; 15(2):750-763.
PMID: 37368331
PMC: 10300807.
DOI: 10.3390/neurolint15020047.
Current Treatments and New, Tentative Therapies for Parkinson's Disease.
Pardo-Moreno T, Garcia-Morales V, Suleiman-Martos S, Rivas-Dominguez A, Mohamed-Mohamed H, Ramos-Rodriguez J
Pharmaceutics. 2023; 15(3).
PMID: 36986631
PMC: 10051786.
DOI: 10.3390/pharmaceutics15030770.
Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
Guo T, Zhang Z, Sun Y, Zhu R, Wang F, Ma L
Nutrients. 2023; 15(4).
PMID: 36839287
PMC: 9960062.
DOI: 10.3390/nu15040930.
Genomics transformer for diagnosing Parkinson's disease.
Reyes D, Kim M, Chao H, Hahn J, Shen L, Yan P
IEEE EMBS Int Conf Biomed Health Inform. 2023; 2022.
PMID: 36824448
PMC: 9942707.
DOI: 10.1109/bhi56158.2022.9926815.
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants.
Hall D, Voigt R, Cantu-Jungles T, Hamaker B, Engen P, Shaikh M
Nat Commun. 2023; 14(1):926.
PMID: 36801916
PMC: 9938693.
DOI: 10.1038/s41467-023-36497-x.
The role of the microbiota-gut-brain axis in long-term neurodegenerative processes following traumatic brain injury.
Chiu L, Anderton R
Eur J Neurosci. 2022; 57(2):400-418.
PMID: 36494087
PMC: 10107147.
DOI: 10.1111/ejn.15892.
Dysbiosis of Gut Microbiota from the Perspective of the Gut-Brain Axis: Role in the Provocation of Neurological Disorders.
Kandpal M, Indari O, Baral B, Jakhmola S, Tiwari D, Bhandari V
Metabolites. 2022; 12(11).
PMID: 36355147
PMC: 9692419.
DOI: 10.3390/metabo12111064.
The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
Varesi A, Campagnoli L, Fahmideh F, Pierella E, Romeo M, Ricevuti G
Int J Mol Sci. 2022; 23(20).
PMID: 36293176
PMC: 9603886.
DOI: 10.3390/ijms232012289.
Effect of altered human exposome on the skin and mucosal epithelial barrier integrity.
Pat Y, Ogulur I, Yazici D, Mitamura Y, Cevhertas L, Kucukkase O
Tissue Barriers. 2022; 11(4):2133877.
PMID: 36262078
PMC: 10606824.
DOI: 10.1080/21688370.2022.2133877.
Neuroprotective Effects of Sodium Butyrate and Monomethyl Fumarate Treatment through GPR109A Modulation and Intestinal Barrier Restoration on PD Mice.
Xu R, Miao W, Xu J, Xu W, Liu M, Ding S
Nutrients. 2022; 14(19).
PMID: 36235813
PMC: 9571500.
DOI: 10.3390/nu14194163.